Prostasin, A Potential Tumor Marker in Ovarian Cancer- A Pilot Study
Open Access
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase–Prostasin serine protease cascade in cultured epithelial cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2008
- Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancerGynecologic Oncology, 2007
- New tumor markers: CA125 and beyondInternational Journal of Gynecological Cancer, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Preoperative Sensitivity and Specificity for Early-Stage Ovarian Cancer When Combining Cancer Antigen CA-125II, CA 15-3, CA 72-4, and Macrophage Colony-Stimulating Factor Using Mixtures of Multivariate Normal DistributionsJournal of Clinical Oncology, 2004
- Down‐regulated expression of prostasin in high‐grade or hormone‐refractory human prostate cancersThe Prostate, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Down‐regulation of prostasin serine protease: A potential invasion suppressor in prostate cancerThe Prostate, 2001
- Blood–Borne RT–PCR Assay for Prostasin– Specific Transcripts to Identify Circulating Prostate Cells in Cancer PatientsEuropean Urology, 2001
- Structure and Chromosomal Localization of the Human Prostasin (PRSS8) GeneGenomics, 1996